• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    US Stocks Mixed; Home Prices Increase In March

    5/28/24 10:05:17 AM ET
    $APDN
    $INSM
    $LUCY
    $MRAI
    Other Consumer Services
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $APDN alert in real time by email

    U.S. stocks traded mixed this morning, with the Dow Jones index falling around 100 points on Tuesday.

    Following the market opening Tuesday, the Dow traded down 0.25% to 38,970.85 while the NASDAQ rose 0.15% to 16,945.48. The S&P 500 also fell, dropping, 0.01% to 5,304.12.

    Check This Out: This Airbnb Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

    Leading and Lagging Sectors

    Energy shares jumped by 1% on Tuesday.

    In trading on Tuesday, health care shares fell by 0.9%.

    Top Headline

    The S&P CoreLogic Case-Shiller home price index rose by 7.4% year-over-year in March versus 7.3% in the previous month.

    Equities Trading UP
                           

    • Sharps Technology, Inc. (NASDAQ:STSS) shares shot up 274% to $0.7977.
    • Shares of Insmed Incorporated (NASDAQ:INSM) got a boost, surging 113% to $46.94.
    • Pineapple Energy Inc. (NASDAQ:PEGY) shares were also up, gaining 90% to $0.3392.

    Equities Trading DOWN

    • Applied DNA Sciences, Inc. (NASDAQ:APDN) shares dropped 66% to $0.68 after the company reported the pricing of $12 million public offering.
    • Shares of Marpai, Inc.  (NASDAQ:MRAI) were down 52% to $0.9293.
    • Innovative Eyewear, Inc. (NASDAQ:LUCY) was down, falling 44% to $0.5488.

    Also Check This Out: Top 5 Real Estate Stocks That Could Lead To Your Biggest Gains This Month

    Commodities

    In commodity news, oil traded up 1.4% to $78.78 while gold traded up 0.6% at $2,347.60.

    Silver traded up 4.3% to $31.795 on Tuesday, while copper rose 1.5% to $4.8260.

    Euro zone

    European shares were lower today. The eurozone's STOXX 600 fell 0.2%, Germany's DAX slipped 0.1% and France's CAC 40 declined 0.6%. Spain's IBEX 35 Index fell 0.1%, while London's FTSE 100 declined 0.3%.

    German wholesale prices fell by 1.8% year-over-year in April compared to a revised 2.6% decline a month ago.

    Asia Pacific Markets

    Asian markets closed lower on Tuesday, with Japan's Nikkei falling 0.11%, China's Composite Index declining 0.46%, Hong Kong's Hang Seng Index falling 0.03% and India's S&P BSE Sensex falling 0.2%.

    Producer prices in Malaysia rose by 1.9% year-over-year in April compared to a 1.6% increase in the earlier month.

    Economics

    • The S&P CoreLogic Case-Shiller home price index rose by 7.4% year-over-year in March versus 7.3% in the previous month.
    • The FHFA house price index rose by 0.1% in March, compared to market expectations of a 0.5% gain.

    Now Read This: How To Earn $500 A Month From Heico Stock Ahead Of Q2 Earnings

    Get the next $APDN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $APDN
    $INSM
    $LUCY
    $MRAI

    CompanyDatePrice TargetRatingAnalyst
    Insmed Incorporated
    $INSM
    1/28/2026$231.00Overweight
    Barclays
    Insmed Incorporated
    $INSM
    1/23/2026$212.00Buy
    Roth Capital
    Insmed Incorporated
    $INSM
    12/19/2025$202.00Buy
    Truist
    Insmed Incorporated
    $INSM
    12/4/2025$263.00Buy
    Rothschild & Co Redburn
    Insmed Incorporated
    $INSM
    10/28/2025$192.00Overweight
    Cantor Fitzgerald
    Insmed Incorporated
    $INSM
    10/20/2025$171.00Overweight
    Wells Fargo
    Insmed Incorporated
    $INSM
    8/20/2025Outperform
    William Blair
    Insmed Incorporated
    $INSM
    8/13/2025$126.00Overweight → Equal-Weight
    Morgan Stanley
    More analyst ratings

    $APDN
    $INSM
    $LUCY
    $MRAI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Barclays initiated coverage on Insmed with a new price target

    Barclays initiated coverage of Insmed with a rating of Overweight and set a new price target of $231.00

    1/28/26 7:17:09 AM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Roth Capital initiated coverage on Insmed with a new price target

    Roth Capital initiated coverage of Insmed with a rating of Buy and set a new price target of $212.00

    1/23/26 8:19:26 AM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Truist resumed coverage on Insmed with a new price target

    Truist resumed coverage of Insmed with a rating of Buy and set a new price target of $202.00

    12/19/25 8:48:21 AM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $APDN
    $INSM
    $LUCY
    $MRAI
    SEC Filings

    View All

    SEC Form 144 filed by Insmed Incorporated

    144 - INSMED Inc (0001104506) (Subject)

    2/5/26 5:12:15 PM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form EFFECT filed by Sharps Technology Inc.

    EFFECT - Sharps Technology Inc. (0001737995) (Filer)

    2/2/26 12:15:19 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Marpai Inc. filed SEC Form 8-K: Leadership Update, Entry into a Material Definitive Agreement

    8-K - Marpai, Inc. (0001844392) (Filer)

    1/23/26 4:02:33 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    $APDN
    $INSM
    $LUCY
    $MRAI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Insmed to Host Fourth-Quarter and Full-Year 2025 Financial Results Conference Call on Thursday, February 19, 2026

    BRIDGEWATER, N.J., Feb. 5, 2026 /PRNewswire/ -- Insmed Incorporated (NASDAQ:INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that it will release its fourth-quarter and full-year 2025 financial results on Thursday, February 19, 2026. Insmed management will host a conference call for investors beginning at 8:00 a.m. ET on Thursday, February 19, 2026, to discuss financial results and provide a business update. Shareholders and other interested parties may participate in the conference call by dialing (888) 210-2654 (U.S.) and (646) 960-0278 (international) an

    2/5/26 7:00:00 AM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Sharps Technology and BitGo Announce Collaboration to Advance Solana Treasury Strategy

    NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. ("STSS" or the "Company") (NASDAQ:STSS), a medical device company with a Solana (SOL) digital asset treasury strategy, and BitGo Bank & Trust, National Association ("BitGo"), the digital asset infrastructure company, today announced a strategic collaboration under which STSS will expand and further institutionalize its Solana treasury strategy through BitGo's services. As part of this arrangement, STSS intends to utilize BitGo's institutional-grade qualified custody through its OCC regulated entity, BitGo Bank & Trust, National Association. In addition, STSS intends to leverage BitGo's Solana staking validator to earn com

    2/5/26 7:00:00 AM ET
    $BTGO
    $STSS
    Finance: Consumer Services
    Finance
    Medical/Dental Instruments
    Health Care

    Insmed to Present Multiple Abstracts on Treprostinil Palmitil Inhalation Powder (TPIP) at Pulmonary Vascular Research Institute (PVRI) 2026 Congress

    —Abstracts Include the Phase 3 PALM-PAH Study Design, a Presentation of the Previously Disclosed Topline Phase 2b PAH Data, a Functional Respiratory Imaging Analysis from the Phase 2b Study in Pulmonary Arterial Hypertension (PAH), and Pulmonary Vasodilation Data in Rat Models— BRIDGEWATER, N.J., Jan. 28, 2026 /PRNewswire/ -- Insmed Incorporated (NASDAQ:INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that it will present four abstracts on treprostinil palmitil inhalation powder (TPIP) at the Pulmonary Vascular Research Institute (PVRI) 2026 congress in Dub

    1/28/26 7:00:00 AM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $APDN
    $INSM
    $LUCY
    $MRAI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ARIKAYCE KIT issued to INSMED INC

    Submission status for INSMED INC's drug ARIKAYCE KIT (SUPPL-13) with active ingredient AMIKACIN SULFATE has changed to 'Approval' on 06/01/2023. Application Category: NDA, Application Number: 207356, Application Classification: Labeling

    6/2/23 4:38:39 AM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ARIKAYCE KIT issued to INSMED INC

    Submission status for INSMED INC's drug ARIKAYCE KIT (SUPPL-12) with active ingredient AMIKACIN SULFATE has changed to 'Approval' on 02/10/2023. Application Category: NDA, Application Number: 207356, Application Classification: Labeling

    2/13/23 4:39:32 AM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $APDN
    $INSM
    $LUCY
    $MRAI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Gross Harrison R. bought $1,980 worth of shares (1,500 units at $1.32), increasing direct ownership by 12% to 13,733 units (SEC Form 4)

    4 - Innovative Eyewear Inc (0001808377) (Issuer)

    1/22/26 11:29:05 AM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Chief Financial Officer Gayle Oswald bought $1,669 worth of shares (1,000 units at $1.67), increasing direct ownership by 54% to 2,865 units (SEC Form 4)

    4 - Innovative Eyewear Inc (0001808377) (Issuer)

    1/15/26 5:00:07 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Chief Executive Officer Gross Harrison R. bought $2,400 worth of shares (1,500 units at $1.60), increasing direct ownership by 14% to 12,233 units (SEC Form 4)

    4 - Innovative Eyewear Inc (0001808377) (Issuer)

    1/12/26 5:00:39 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    $APDN
    $INSM
    $LUCY
    $MRAI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Mcgirr David W J gifted 53,400 shares and received a gift of 53,400 shares, decreasing direct ownership by 55% to 44,323 units (SEC Form 4)

    4 - INSMED Inc (0001104506) (Issuer)

    2/11/26 4:43:08 PM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chair and CEO Lewis William exercised 10,699 shares at a strike of $24.94 and sold $1,979,764 worth of shares (13,396 units at $147.79), decreasing direct ownership by 0.89% to 301,185 units (SEC Form 4)

    4 - INSMED Inc (0001104506) (Issuer)

    2/11/26 4:42:22 PM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Medical Officer Flammer Martina M.D. sold $132,470 worth of shares (869 units at $152.44), decreasing direct ownership by 1% to 83,243 units (SEC Form 4)

    4 - INSMED Inc (0001104506) (Issuer)

    2/6/26 4:18:50 PM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $APDN
    $INSM
    $LUCY
    $MRAI
    Financials

    Live finance-specific insights

    View All

    Insmed to Host Fourth-Quarter and Full-Year 2025 Financial Results Conference Call on Thursday, February 19, 2026

    BRIDGEWATER, N.J., Feb. 5, 2026 /PRNewswire/ -- Insmed Incorporated (NASDAQ:INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that it will release its fourth-quarter and full-year 2025 financial results on Thursday, February 19, 2026. Insmed management will host a conference call for investors beginning at 8:00 a.m. ET on Thursday, February 19, 2026, to discuss financial results and provide a business update. Shareholders and other interested parties may participate in the conference call by dialing (888) 210-2654 (U.S.) and (646) 960-0278 (international) an

    2/5/26 7:00:00 AM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Insmed Provides Clinical and Business Update

    —Phase 2b BiRCh Study of Brensocatib in CRSsNP Did Not Meet Primary or Secondary Efficacy Endpoints; Safety Consistent with Previous Studies; Insmed Discontinues CRSsNP Program— —Company Acquires Phase 2 Ready Monoclonal Antibody for Potential Respiratory and Immunological & Inflammatory Indications— BRIDGEWATER, N.J., Dec. 17, 2025 /PRNewswire/ -- Insmed Incorporated (NASDAQ:INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, announced today that the Phase 2b BiRCh study of brensocatib in patients with chronic rhinosinusitis without nasal polyps (CRSsNP) did not meet its pri

    12/17/25 4:01:00 PM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Annual Changes to the Nasdaq-100 Index®

    NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced the results of the annual reconstitution of the Nasdaq-100 Index® (NDX®), which will become effective prior to market open on Monday, December 22, 2025. The following six companies will be added to the Index: Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), Ferrovial SE (NASDAQ:FER), Insmed Incorporated (NASDAQ:INSM), Monolithic Power Systems, Inc. (NASDAQ:MPWR), Seagate Technology Holdings plc (NASDAQ:STX), Western Digital Corp. (NASDAQ:WDC). The Nasdaq-100 Index is a globally recognized index that tracks the performance of 100 of the largest non-financial companies listed on the Nasdaq Stock Market® encompassi

    12/12/25 8:00:00 PM ET
    $ALNY
    $BIIB
    $CDW
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)
    Retail: Computer Software & Peripheral Equipment

    $APDN
    $INSM
    $LUCY
    $MRAI
    Leadership Updates

    Live Leadership Updates

    View All

    MARPAI, INC. HIRES PHARMACY EXECUTIVE MIMI DAVIS AS PRESIDENT OF MARPAIRX TO DRIVE STRATEGIC GROWTH

    TAMPA, Fla., Jan. 27, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Pharmacy Benefit Management (PBM) and Third-Party Administration (TPA) services, announced the hiring of Mimi Davis as President of MarpaiRx. Davis, a distinguished leader in the pharmacy services sector, will oversee the strategic expansion and operational scaling of Marpai's pharmacy benefit offerings. Davis joins Marpai from Knipper Health, where she served as Executive Vice President of Operations. Her deep industry roots include a significant tenure at Eagle Pharmacy—a former HillCour portfolio company—which was acquired by Knipper in 2020. With

    1/27/26 8:23:00 AM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    OMass Therapeutics Appoints Carol A. Schafer as Non-Executive Director and Chair of the Audit Committee

    PRESS RELEASE OMass Therapeutics Appoints Carol A. Schafer as Non-Executive Director and Chair of the Audit Committee Oxford, United Kingdom – 6th August 2025 – OMass Therapeutics (‘OMass' or ‘the Company'), a biotechnology company identifying medicines against highly validated target ecosystems such as membrane proteins or intracellular complexes, today announces the appointment of Carol A. Schafer as non-executive Director and Chair of the Audit Committee. Carol has more than 25 years of experience in investment banking, equity capital markets, corporate finance and business development in the healthcare sector. She currently serves on the Board of Directors for Insmed Incorporated (NAS

    8/6/25 7:00:00 AM ET
    $IMNM
    $INSM
    $KURA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Innovative Eyewear, Inc. Announces Exciting New Features for the Lucyd ChatGPT App

    MIAMI, May 29, 2025 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (NASDAQ:LUCY, LUCYW)), the manufacturer of smart eyewear under the Lucyd®, Lucyd Armor®, Reebok®, Eddie Bauer® and Nautica® brands, is pleased to announce a powerful new update to the Company's Lucyd app for iOS and Android. The Lucyd app was the first to enable voice access to ChatGPT in smart eyewear, and the Company believes these latest enhancements further advance its market position as a leader in smart eyewear.   Below are the new updates: App Shopping. Both the iOS and

    5/29/25 8:00:00 AM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    $APDN
    $INSM
    $LUCY
    $MRAI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Marpai Inc.

    SC 13D/A - Marpai, Inc. (0001844392) (Subject)

    12/9/24 5:14:07 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13G filed by Applied DNA Sciences Inc.

    SC 13G - APPLIED DNA SCIENCES INC (0000744452) (Subject)

    11/14/24 5:46:25 PM ET
    $APDN
    Other Consumer Services
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Insmed Incorporated

    SC 13G/A - INSMED Inc (0001104506) (Subject)

    11/14/24 1:22:37 PM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care